N,N'-Alkane-diyl-bis-3-picoliniums as nicotinic receptor antagonists: inhibition of nicotine-evoked dopamine release and hyperactivity. The Journal Of Pharmacology And Experimental Therapeutics, 326(2), 563-76. https://doi.org/10.1124/jpet.108.136630
. (2008).